Pharmalicensing.com
Latest: Watch here for details of new products and services.
RSS Feeds
Advanced search

Login  Register

Our Products
Overview
Partnering Search
Company Profiling
Partneringtools
Reports
Partnering Consulting
Comparison
 
Forums
Visit our forums
 
Jobs
Visit our job site
 
Case Studies
See what others think about our service
 
Newsletter
Partnering update
Key reports
Subscribe
 
Quick Links
Profile now
Register now
Profiled companies
Featured events
Industry news
PR Newswire New!
 
Contact us
Send an email
Call us: +44 1904 520460
Request a callback
 
RSS Feeds
Keep up to date

Pharmalicensing Ltd
is a division of
UTEK Corporation
Companies

Jaleva LLC

Jaleva LLC
Jaleva is a leader in the application of resin technology for the improvement of topical medications.

The company in detail

Profile

Jaleva is a leader in the application of resin technology for the improvement of topical medications. Our current products include: - Stayzon Surgical Adhesive Plus Antibiotic, a post op wound care product which is a surgical adhesive that keeps bandages and antibiotics in place simultaneously. - Stayzon Formulation for Heels, a highly effective product for cracked heels. - Formulations currently being tested include Stayzon® for onychomycosis. Our product line called Stayzon® is a patented vehicle for topical and oral care medications that safely and dramatically improves their efficacy. Stayzon combined with active ingredients is superior to other delivery systems by keeping actives in place for longer periods of time.

Partnering strategy/interests

We seek a partner who will license our Intellectual Property. Our licensing partner should be able to both manufacture and market our product in the US

Out-licensing

Stayzon's surgical prep product with Chlorhexidine is a unique 3 for 1 combination product. The mastic gum based product kills bacteria with Chlorhexidine, prevents bacterial migration, and allows drapes to stick better than other prep products. More

Press Releases

(15th Sep 2008) Jaleva announces that MICROBIOTEST has completed a clinical trial comparing Chloraprep to Mast-r-Prep, Jaleva’s proprietary, CHG-based, surgical skin prep product. Mast-r-Prep safely killed more bacteria for a longer period of time than Chloraprep. More
(2nd Jun 2008) Jaleva Pharmaceuticals LLC announces that MICROBIOTEST has completed Time Kill and MIC studies for Mast-R-Prep, the company's propietary, chlorhexidine-based, one-step surgical skin prep product. The MIC and Time Kill results were outstanding. Mast More
(2nd Jun 2008) Jaleva Pharmaceuticals LLC announces that market research results from FRANKLIN COMMUNICATIONS indicate that Mast-R-Prep, the company's propietary, chlorhexidine-based, one-step surgical skin prep, has the characteristics most desirable to surgeons. More
(18th Apr 2006) Stayzon Surgical Adhesive + Antibiotic, the company's proprietary surgical adhesive, produced no evidence of irritation under the conditions of the test. More
Partnering consultation free of charge
Cell & Gene Therapy Forum 2009
Need competitive intelligence information
Industry news: Pharmalicensing provides comprehensive industry coverage.

© Copyright 1995-2008 Pharmalicensing Ltd, is a division of UTEK Corporation All rights reserved. Terms and Conditions | Site map | Contact us